Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?

Antiviral Research

Volumn 85, Issue 1, 2010, Pages 295-302

  Blankson, Joel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4; CD8; Elite controller; Elite suppressor; Escape mutations; HLA B*27; HLA B*57; Long term non progressor; Neutralizing antibody

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HLA B57 ANTIGEN; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; TOLL LIKE RECEPTOR; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; REPLICATION COMPETENT VIRUSES;

EID: 73549099347     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.08.007     Document Type: Review

References (121)

1. Addo M.M., Yu X.G., Rathod A., Cohen D., Eldridge R.L., Strick D., Johnston M.N., Corcoran C., Wurcel A.G., Fitzpatrick C.A., et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77 (2003) 2081-2092
2. Alexander L., Aquino-DeJesus M.J., Chan M., and Andiman W.A. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child. J. Virol. 76 (2002) 10533-10539
3. Alexander L., Weiskopf E., Greenough T.C., Gaddis N.C., Auerbach M.R., Malim M.H., O'Brien S.J., Walker B.D., Sullivan J.L., and Desrosiers R.C. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J. Virol. 74 (2000) 4361-4376
4. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., Asher T.E., Samri A., Schnuriger A., Theodorou I., et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204 (2007) 2473-2485
5. Altfeld M., Addo M.M., Rosenberg E.S., Hecht F.M., Lee P.K., Vogel M., Yu X.G., Draenert R., Johnston M.N., Strick D., et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17 (2003) 2581-2591
6. Altfeld M., Kalife E.T., Qi Y., Streeck H., Lichterfeld M., Johnston M.N., Burgett N., Swartz M.E., Yang A., Alter G., et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med. 3 (2006) e403
7. Andrade A., Bailey J.R., Xu J., Philp F.H., Quinn T.C., Williams T.M., Ray S.C., Thomas D.L., and Blankson J.N. CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load. Clin. Infect. Dis. 46 (2008) e78-82
8. Bailey J.R., Brennan T.P., O'Connell K.A., Siliciano R.F., and Blankson J.N. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite controllers. J. Virol. 83 (2009) 88-97
9. Bailey J.R., Lassen K.G., Yang H.C., Quinn T.C., Ray S.C., Blankson J.N., and Siliciano R.F. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite controllers or selection of plasma virus variants in patients on highly active antiretroviral therapy. J. Virol. 80 (2006) 4758-4770
10. Bailey J.R., O'Connell K., Yang H.C., Han Y., Xu J., Jilek B., Williams T.M., Ray S.C., Siliciano R.F., and Blankson J.N. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite controller. J. Virol. 82 (2008) 7395-7410
11. Bailey J.R., Williams T.M., Siliciano R.F., and Blankson J.N. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite controllers despite CTL escape mutations. J. Exp. Med. 203 (2006) 1357-1369
12. Bailey J.R., Zhang H., Wegweiser B.W., Yang H.C., Herrera L., Ahonkhai A., Williams T.M., Siliciano R.F., and Blankson J.N. Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape. J. Infect. Dis. 196 (2007) 50-55
13. Barker E., Martinson J., Brooks C., Landay A., and Deeks S. Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy. AIDS 21 (2007) 2363-2365
14. Beignon A.S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., Larsson M., Gorelick R.J., Lifson J.D., and Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115 (2005) 3265-3275
15. Betts M.R., Ambrozak D.R., Douek D.C., Bonhoeffer S., Brenchley J.M., Casazza J.P., Koup R.A., and Picker L.J. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75 (2001) 11983-11991
16. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., Lederman M.M., Benito J.M., Goepfert P.A., Connors M., Roederer M., and Koup R.A. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 (2006) 4781-4789
17. Blankson J.N., Bailey J.R., Thayil S., Yang H.C., Lassen K., Lai J., Gandhi S.K., Siliciano J.D., Williams T.M., and Siliciano R.F. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite controllers. J. Virol. 81 (2007) 2508-2518
18. Blankson J.N., Finzi D., Pierson T.C., Sabundayo B.P., Chadwick K., Margolick J.B., Quinn T.C., and Siliciano R.F. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection. J. Infect. Dis. 182 (2000) 1636-1642
19. Blankson J.N., Gallant J.E., Quinn T.C., Bartlett J.G., and Siliciano R.F. Loss of HIV-1-specific immunity during treatment interruption in 2 chronically infected patients. JAMA 288 (2002) 162-164
20. Bochud P.Y., Hersberger M., Taffe P., Bochud M., Stein C.M., Rodrigues S.D., Calandra T., Francioli P., Telenti A., Speck R.F., Aderem A., and Swiss HIV Cohort Study. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21 (2007) 441-446
21. Borrow P., Lewicki H., Hahn B.H., Shaw G.M., and Oldstone M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68 (1994) 6103-6110
22. Boutwell C.L., Rowley C.F., and Essex M. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J. Virol. 83 (2009) 2460-2468
23. Brockman M.A., Schneidewind A., Lahaie M., Schmidt A., Miura T., Desouza I., Ryvkin F., Derdeyn C.A., Allen S., Hunter E., et al. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 81 (2007) 12608-12618
24. Buchbinder S., and Vittinghoff E. HIV-infected long-term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications. Microb. Infect. 1 (1999) 1113-1120
25. Calugi G., Montella F., Favalli C., and Benedetto A. Entire genome of a strain of human immunodeficiency virus type 1 with a deletion of nef that was recovered 20 years after primary infection: large pool of proviruses with deletions of env. J. Virol. 80 (2006) 11892-11896
26. Catano G., Kulkarni H., He W., Marconi V.C., Agan B.K., Landrum M., Anderson S., Delmar J., Telles V., Song L., et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3 (2008) e3636
27. Chase A.J., Yang H.C., Zhang H., Blankson J.N., and Siliciano R.F. Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite controllers correlates with low CD4+ T-cell activation. J. Virol. 82 (2008) 8307-8315
28. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., and Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10 (1999) 661-671
29. Crawford H., Lumm W., Leslie A., Schaefer M., Boeras D., Prado J.G., Tang J., Farmer P., Ndung'u T., Lakhi S., et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. (2009)
30. Dalmasso C., Carpentier W., Meyer L., Rouzioux C., Goujard C., Chaix M.L., Lambotte O., Avettand-Fenoel V., Le Clerc S., de Senneville L.D., et al. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS ONE 3 (2008) e3907
31. de Quiros J.C., Shupert W.L., McNeil A.C., Gea-Banacloche J.C., Flanigan M., Savage A., Martino L., Weiskopf E.E., Imamichi H., Zhang Y.M., et al. Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen. J. Virol. 74 (2000) 2023-2028
32. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270 (1995) 988-991
33. Deeks S.G., Schweighardt B., Wrin T., Galovich J., Hoh R., Sinclair E., Hunt P., McCune J.M., Martin J.N., Petropoulos C.J., and Hecht F.M. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J. Virol. 80 (2006) 6155-6164
34. Dinoso J.B., Kim S.Y., Siliciano R.F., and Blankson J.N. A comparison of viral loads between HIV-1-infected elite controllers and individuals who receive suppressive highly active antiretroviral therapy. Clin. Infect. Dis. 47 (2008) 102-104
35. Doria-Rose N.A., Klein R.M., Manion M.M., O'Dell S., Phogat A., Chakrabarti B., Hallahan C.W., Migueles S.A., Wrammert J., Ahmed R., et al. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J. Virol. 83 (2009) 188-199
36. Douek D.C., Brenchley J.M., Betts M.R., Ambrozak D.R., Hill B.J., Okamoto Y., Casazza J.P., Kuruppu J., Kunstman K., Wolinsky S., et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417 (2002) 95-98
37. Dyer W.B., Zaunders J.J., Yuan F.F., Wang B., Learmont J.C., Geczy A.F., Saksena N.K., McPhee D.A., Gorry P.R., and Sullivan J.S. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection. Retrovirology 5 (2008) 112
38. Emu B., Sinclair E., Favre D., Moretto W.J., Hsue P., Hoh R., Martin J.N., Nixon D.F., McCune J.M., and Deeks S.G. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J. Virol. 79 (2005) 14169-14178
39. Emu B., Sinclair E., Hatano H., Ferre A., Shacklett B., Martin J.N., McCune J.M., and Deeks S.G. HLA class I-restricted T cell responses may contribute to the control of HIV Infection, but such responses are not always necessary for long-term virus control. J. Virol. (2008)
40. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317 (2007) 944-947
41. Ferre A.L., Hunt P.W., Critchfield J.W., Young D.H., Morris M.M., Garcia J.C., Pollard R.B., Yee Jr. H.F., Martin J.N., Deeks S.G., and Shacklett B.L. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 113 (2009) 3978-3989
42. Finzi D., Blankson J., Siliciano J.D., Margolick J.B., Chadwick K., Pierson T., Smith K., Lisziewicz J., Lori F., Flexner C., et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999) 512-517
43. Fonteneau J.F., Larsson M., Beignon A.S., McKenna K., Dasilva I., Amara A., Liu Y.J., Lifson J.D., Littman D.R., and Bhardwaj N. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78 (2004) 5223-5232
44. Gandhi S.K., Siliciano J.D., Bailey J.R., Siliciano R.F., and Blankson J.N. Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite controllers. J. Virol. 82 (2008) 3125-3130
45. Goila-Gaur R., and Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5 (2008) 51
46. Goonetilleke N., Liu M.K., Salazar-Gonzalez J.F., Ferrari G., Giorgi E., Ganusov V.V., Keele B.F., Learn G.H., Turnbull E.L., Salazar M.G., et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206 (2009) 1253-1272
47. Grabar S., Selinger-Leneman H., Abgrall S., Pialoux G., Weiss L., and Costagliola D. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS 23 (2009) 1163-1169
48. Greenough T.C., Sullivan J.L., and Desrosiers R.C. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N. Engl. J. Med. 340 (1999) 236-237
49. Han Y., Lai J., Barditch-Crovo P., Gallant J.E., Williams T.M., Siliciano R.F., and Blankson J.N. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite controllers. AIDS 22 (2008) 541-544
50. Hatano H., Delwart E.L., Norris P.J., Lee T.H., Dunn-Williams J., Hunt P.W., Hoh R., Stramer S.L., Linnen J.M., McCune J.M., et al. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J. Virol. 83 (2009) 329-335
51. Huang Y., Zhang L., and Ho D.D. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 240 (1998) 36-49
52. Hunt P.W., Brenchley J., Sinclair E., McCune J.M., Roland M., Page-Shafer K., Hsue P., Emu B., Krone M., Lampiris H., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197 (2008) 126-133
53. Iversen A.K., Shpaer E.G., Rodrigo A.G., Hirsch M.S., Walker B.D., Sheppard H.W., Merigan T.C., and Mullins J.I. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J. Virol. 69 (1995) 5743-5753
54. Jagannathan P., Osborne C.M., Royce C., Manion M.M., Tilton J.C., Li L., Fischer S., Hallahan C.W., Metcalf J.A., McLaughlin M., et al. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J. Virol. 83 (2009) 2728-2742
55. Jansen C.A., Kostense S., Vandenberghe K., Nanlohy N.M., De Cuyper I.M., Piriou E., Manting E.H., Miedema F., and van Baarle D. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur. J. Immunol. 35 (2005) 150-158
56. Kaufmann D.E., Kavanagh D.G., Pereyra F., Zaunders J.J., Mackey E.W., Miura T., Palmer S., Brockman M., Rathod A., Piechocka-Trocha A., et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8 (2007) 1246-1254
57. Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432 (2004) 769-775
58. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., and Desrosiers R.C. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332 (1995) 228-232
59. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., and Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68 (1994) 4650-4655
60. Laeyendecker O., Rothman R.E., Henson C., Horne B.J., Ketlogetswe K.S., Kraus C.K., Shahan J., Kelen G.D., and Quinn T.C. The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department. J. Acquir. Immune Defic. Syndr. 48 (2008) 211-215
61. Lambotte O., Boufassa F., Madec Y., Nguyen A., Goujard C., Meyer L., Rouzioux C., Venet A., Delfraissy J.F., and SEROCO-HEMOCO Study Group. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin. Infect. Dis. 41 (2005) 1053-1056
62. Lambotte O., Ferrari G., Moog C., Yates N.L., Liao H.X., Parks R.J., Hicks C.B., Owzar K., Tomaras G.D., Montefiori D.C., Haynes B.F., and Delfraissy J.F. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23 (2009) 897-906
63. Lamine A., Caumont-Sarcos A., Chaix M.L., Saez-Cirion A., Rouzioux C., Delfraissy J.F., Pancino G., and Lambotte O. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 21 (2007) 1043-1045
64. Lassen K.G., Lobritz M.A., Bailey J.R., Johnston S., Nguyen S., Lee B., Chou T., Siliciano R.F., Markowitz M., and Arts E.J. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog. 4 (2009) e 1000377
65. Lasker M.V., and Nair S.K. Intracellular TLR signaling: a structural perspective on human disease. J. Immunol. 177 (2006) 11-16
66. Lecuroux C., Girault I., Boutboul F., Urrutia A., Goujard C., Meyer L., Lambotte O., Chaix M.L., Martinez V., Autran B., et al. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells. AIDS (2009)
67. Lecuroux C., Girault I., Urrutia A., Doisne J.M., Deveau C., Goujard C., Meyer L., Sinet M., and Venet A. Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection. Blood 113 (2009) 3209-3217
68. Lefrere J.J., Morand-Joubert L., Mariotti M., Bludau H., Burghoffer B., Petit J.C., and Roudot-Thoraval F. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 90 (1997) 1133-1140
69. Leslie A.J., Pfafferott K.J., Chetty P., Draenert R., Addo M.M., Feeney M., Tang Y., Holmes E.C., Allen T., Prado J.G., et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10 (2004) 282-289
70. Li Y., Migueles S.A., Welcher B., Svehla K., Phogat A., Louder M.K., Wu X., Shaw G.M., Connors M., Wyatt R.T., and Mascola J.R. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat. Med. 13 (2007) 1032-1034
71. Lichterfeld M., Mou D., Cung T.D., Williams K.L., Waring M.T., Huang J., Pereyra F., Trocha A., Freeman G.J., Rosenberg E.S., Walker B.D., and Yu X.G. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood 112 (2008) 3679-3687
72. Limou S., Le Clerc S., Coulonges C., Carpentier W., Dina C., Delaneau O., Labib T., Taing L., Sladek R., Deveau C., et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J. Infect. Dis. 199 (2009) 419-426
73. Loffredo J.T., Sidney J., Bean A.T., Beal D.R., Bardet W., Wahl A., Hawkins O.E., Piaskowski S., Wilson N.A., Hildebrand W.H., Watkins D.I., and Sette A. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J. Immunol. 182 (2009) 7763-7775
74. Madec, Y., Boufassa, F., Porter, K., Meyer, L., and CASCADE Collaboration. (2005). Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS 19, 2001-2007.
75. Mahalanabis M., Jayaraman P., Miura T., Pereyra F., Chester E.M., Richardson B., Walker B., and Haigwood N.L. Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers. J. Virol. 83 (2009) 662-672
76. Mariani R., Kirchhoff F., Greenough T.C., Sullivan J.L., Desrosiers R.C., and Skowronski J. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70 (1996) 7752-7764
77. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., Buchbinder S., Hoots K., Vlahov D., Trowsdale J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31 (2002) 429-434
78. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., Colombo S., Brown E.E., Shupert W.L., Phair J., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39 (2007) 733-740
79. Martinez-Picado J., Prado J.G., Fry E.E., Pfafferott K., Leslie A., Chetty S., Thobakgale C., Honeyborne I., Crawford H., Matthews P., et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80 (2006) 3617-3623
80. McNeil A.C., Shupert W.L., Iyasere C.A., Hallahan C.W., Mican J.A., Davey Jr. R.T., and Connors M. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13878-13883
81. Michael N.L., Chang G., d'Arcy L.A., Ehrenberg P.K., Mariani R., Busch M.P., Birx D.L., and Schwartz D.H. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69 (1995) 4228-4236
82. Migueles S.A., Laborico A.C., Imamichi H., Shupert W.L., Royce C., McLaughlin M., Ehler L., Metcalf J., Liu S., Hallahan C.W., and Connors M. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77 (2003) 6889-6898
83. Migueles S.A., Laborico A.C., Shupert W.L., Sabbaghian M.S., Rabin R., Hallahan C.W., Van Baarle D., Kostense S., Miedema F., McLaughlin M., et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3 (2002) 1061-1068
84. Migueles S.A., Osborne C.M., Royce C., Compton A.A., Joshi R.P., Weeks K.A., Rood J.E., Berkley A.M., Sacha J.B., Cogliano-Shutta N.A., et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29 (2008) 1009-1021
85. Migueles S.A., Sabbaghian M.S., Shupert W.L., Bettinotti M.P., Marincola F.M., Martino L., Hallahan C.W., Selig S.M., Schwartz D., Sullivan J., and Connors M. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2709-2714
86. Miura T., Brockman M.A., Brumme C.J., Brumme Z.L., Carlson J.M., Pereyra F., Trocha A., Addo M.M., Block B.L., Rothchild A.C., et al. Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes. J. Virol. 82 (2008) 8422-8430
87. Miura T., Brockman M.A., Brumme Z.L., Brumme C.J., Pereyra F., Trocha A., Block B.L., Schneidewind A., Allen T.M., Heckerman D., and Walker B.D. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J. Virol. 83 (2009) 140-149
88. Miura T., Brockman M.A., Schneidewind A., Lobritz M., Pereyra F., Rathod A., Block B.L., Brumme Z.L., Brumme C.J., Baker B., et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphotye recognition. J. Virol. 83 (2009) 2743-2755
89. Navis M., Schellens I., van Baarle D., Borghans J., van Swieten P., Miedema F., Kootstra N., and Schuitemaker H. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection. J. Immunol. 179 (2007) 3133-3143
90. Navis M., Schellens I.M., van Swieten P., Borghans J.A., Miedema F., Kootstra N.A., van Baarle D., and Schuitemaker H. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef. J. Infect. Dis. 197 (2008) 871-879
91. Norris P.J., Moffett H.F., Yang O.O., Kaufmann D.E., Clark M.J., Addo M.M., and Rosenberg E.S. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. J. Virol. 78 (2004) 8844-8851
92. Nou E., Zhou Y., Nou D.D., and Blankson J.N. Effective downregulation of HLA-A*2 and HLA-B*57 by primary human immunodeficiency virus type 1 isolates cultured from elite controllers. J. Virol. 83 (2009) 6941-6946
93. O'Connell K.A., Han Y., Williams T.M., Siliciano R.F., and Blankson J.N. Role of natural killer cells in a cohort of elite controllers: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J. Virol. 83 (2009) 5028-5034
94. O'Connell, K.A., Xu, J., Durbin, A.P., Apuzzo, L.G., Imteyaz, H., Williams, T.M., Ray, S.C., Margolick, J.B., Siliciano, R.F., Blankson, J.N. (in press). HIV-1 Evolution Following Transmission to an HLA-B*5801 Positive Subject. J. Infect. Dis.
95. Oxenius A., Price D.A., Easterbrook P.J., O'Callaghan C.A., Kelleher A.D., Whelan J.A., Sontag G., Sewell A.K., and Phillips R.E. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3382-3387
96. Pereyra F., Addo M.M., Kaufmann D.E., Liu Y., Miura T., Rathod A., Baker B., Trocha A., Rosenberg R., Mackey E., et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197 (2008) 563-571
97. Potter S.J., Lacabaratz C., Lambotte O., Perez-Patrigeon S., Vingert B., Sinet M., Colle J.H., Urrutia A., Scott-Algara D., Boufassa F., et al. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J. Virol. 81 (2007) 13904-13915
98. Rachinger A., Navis M., van Assen S., Groeneveld P.H., and Schuitemaker H. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection. Clin. Infect. Dis. 47 (2008) e86-e89
99. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., and Walker B.D. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278 (1997) 1447-1450
100. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., Robbins G.K., D'Aquila R.T., Goulder P.J., and Walker B.D. Immune control of HIV-1 after early treatment of acute infection. Nature 407 (2000) 523-526
101. Sacha J.B., Giraldo-Vela J.P., Buechler M.B., Martins M.A., Maness N.J., Chung C., Wallace L.T., Leon E.J., Friedrich T.C., Wilson N.A., Hiraoka A., and Watkins D.I. Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 9791-9796
102. Saez-Cirion A., Lacabaratz C., Lambotte O., Versmisse P., Urrutia A., Boufassa F., Barre-Sinoussi F., Delfraissy J.F., Sinet M., Pancino G., Venet A., and Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 6776-6781
103. Saez-Cirion A., Sinet M., Shin S.Y., Urrutia A., Versmisse P., Lacabaratz C., Boufassa F., Avettand-Fenoel V., Rouzioux C., Delfraissy J.F., et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J. Immunol. 182 (2009) 7828-7837
104. Sajadi M.M., Constantine N.T., Mann D.L., Charurat M., Dadzan E., Kadlecik P., and Redfield R.R. Epidemiologic characteristics and natural history of HIV-1 natural viral controllers. J. Acquir. Immune Defic. Syndr. 50 (2009) 403-408
105. Salvi R., Garbuglia A.R., Di Caro A., Pulciani S., Montella F., and Benedetto A. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J. Virol. 72 (1998) 3646-3657
106. Scheid J.F., Mouquet H., Feldhahn N., Seaman M.S., Velinzon K., Pietzsch J., Ott R.G., Anthony R.M., Zebroski H., Hurley A., et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458 (2009) 636-640
107. Schito A.M., Vittinghoff E., Hecht F.M., Elkins M.K., Kahn J.O., Levy J.A., and Oksenberg J.R. Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy. Blood 97 (2001) 214-220
108. Seddiki N., and Kelleher A.D. Regulatory T cells in HIV infection: who's suppressing what?. Curr. HIV/AIDS Rep. 5 (2008) 20-26
109. Sedaghat, A.R., Rastegar, D.A., O'Connell, K.A., Dinoso, J.B., Wilke, C.O., Blankson, J.N. (in press). T Cell Dynamics and The Response to HAART in a Cohort of HIV-1 Infected Elite Suppressors. Clin. Infect. Dis.
110. Shrestha S., Aissani B., Song W., Wilson C.M., Kaslow R.A., and Tang J. Host genetics and HIV-1 viral load set-point in African-Americans. AIDS 23 (2009) 673-677
111. Siliciano J.D., Kajdas J., Finzi D., Quinn T.C., Chadwick K., Margolick J.B., Kovacs C., Gange S.J., and Siliciano R.F. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9 (2003) 727-728
112. Soumelis V., Scott I., Gheyas F., Bouhour D., Cozon G., Cotte L., Huang L., Levy J.A., and Liu Y.J. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98 (2001) 906-912
113. Tilton J.C., Luskin M.R., Johnson A.J., Manion M., Hallahan C.W., Metcalf J.A., McLaughlin M., Davey Jr. R.T., and Connors M. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J. Virol. 81 (2007) 2713-2725
114. van Grevenynghe J., Procopio F.A., He Z., Chomont N., Riou C., Zhang Y., Gimmig S., Boucher G., Wilkinson P., Shi Y., et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat. Med. 14 (2008) 266-274
115. van Manen D., Kootstra N.A., Boeser-Nunnink B., Handulle M.A., van't Wout A.B., and Schuitemaker H. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23 (2009) 19-28
116. Wang B., Dyer W.B., Zaunders J.J., Mikhail M., Sullivan J.S., Williams L., Haddad D.N., Harris G., Holt J.A., Cooper D.A., et al. Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection. Virology 304 (2002) 246-264
117. Wang B., Mikhail M., Dyer W.B., Zaunders J.J., Kelleher A.D., and Saksena N.K. First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection. Virology 312 (2003) 135-150
118. Westrop S.J., Qazi N.A., Pido-Lopez J., Nelson M.R., Gazzard B., Gotch F.M., and Imami N. Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers. PLoS ONE 4 (2009) e5474
119. Yamada T., and Iwamoto A. Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection. Arch. Virol. 145 (2000) 1021-1027
120. Zaunders J.J., Ip S., Munier M.L., Kaufmann D.E., Suzuki K., Brereton C., Sasson S.C., Seddiki N., Koelsch K., Landay A., et al. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J. Virol. 80 (2006) 10162-10172
121. Zimmerli S.C., Harari A., Cellerai C., Vallelian F., Bart P.A., and Pantaleo G. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 7239-7244